Pharmanews

Summary: -Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials…

Summary : Sperogenix will receive exclusive rights for development and commercialization of vamorolone for the treatment of Duchenne muscular dystrophy (DMD) and any other rare disease Santhera to receive a double-digit upfront cash payment plus…

Synopsis: -Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued its decision upholding the validity of US…

Summary: ALLN-346, an orally administered enzyme in development for the treatment of hyperuricemia and gout, demonstrates a statistically significant reduction in serum…

Summary ; -Oncoheroes will fund and advance the clinical development of both dovitinib and stenoparib in pediatric cancers, utilizing Allarity’s DRP® companion…

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical President & CEO Gerald…

Summary : Received the CES 2022 Innovation Awards in Health and Wellness following a CES 2018 Best of Innovation Award in VR/AR…

Synopsis; – The Drugs Technical Advisory Board (DTAB) has recommended introduction of barcode or QR code in the top 300 brands of…

Summary : –  Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein – Together…

Bioretec Ltd a globally operating Finnish medical device company, announced that the company has submitted an application for the CE mark for…